INR 134.55
(-1.42%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -69.27 Million | -25.01 Million | 12.9 Million | 135.19 Million | 40.97 Million | 125.49 Million |
Net Income | 42.83 Million | -336 Thousand | 67.9 Million | 9.48 Million | 40.24 Million | 32.25 Million |
Depreciation & Amortization | 20.21 Million | 19.54 Million | 16.6 Million | 16.7 Million | 17.62 Million | 16.86 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -73.23 Million | -4.36 Million | -27.1 Million | 146.08 Million | 7.66 Million | 117.39 Million |
Other non-cash items | 69.69 Million | -39.85 Million | -44.5 Million | -37.07 Million | -24.55 Million | -41.01 Million |
Investing Cash Flow | 40.57 Million | 20.75 Million | -27.9 Million | -145.01 Million | -12.83 Million | -151.35 Million |
Investments in PPE | -3.36 Million | -40.48 Million | -14 Million | - | -52.09 Million | -46.52 Million |
Acquisitions | - | 175 Thousand | 2.7 Million | 19.7 Million | 8.66 Million | 43.67 Million |
Investment purchases | -5.56 Million | -175 Thousand | -33 Million | -170.38 Million | -8.66 Million | -152.83 Million |
Sales/Maturities of investments | - | 34.26 Million | -2.7 Million | - | 23.41 Million | 4.57 Million |
Other Investing Activities | 49.5 Million | 26.97 Million | 19.1 Million | 5.66 Million | 15.84 Million | -252.66 Thousand |
Financing Cash Flow | 20.26 Million | 11.08 Million | 9.7 Million | -98.29 Million | 72.44 Million | -3.44 Million |
Debt repayment | -30.05 Million | -17.33 Million | -21.61 Million | -10.38 Million | -85.38 Million | - |
Dividends payments | - | -7.4 Million | -7.4 Million | -7.82 Million | -8.9 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -9.79 Million | 35.81 Million | 38.71 Million | -80.08 Million | 165.22 Million | -3.44 Million |
Accounts receivables | -29.6 Million | 36.57 Million | 6.06 Million | 45.77 Million | 198.92 Million | 27.04 Million |
Accounts payables | -119.49 Million | 67.29 Million | 25.5 Million | -50.07 Million | -92.39 Million | 104.8 Million |
Inventory | 60.75 Million | -153.68 Million | -81.7 Million | 168.6 Million | 14.86 Thousand | -85.17 Million |
Other working capital | 15.11 Million | 45.44 Million | 23.03 Million | -18.23 Million | -98.88 Million | 70.71 Million |
Cash at beginning of period | 12.96 Million | 6.15 Million | 11.5 Million | 119.56 Million | 18.97 Million | 48.27 Million |
Cash at end of period | 4.52 Million | 12.96 Million | 6.2 Million | 11.45 Million | 119.56 Million | 18.97 Million |
Capital Expenditure | -3.36 Million | -40.48 Million | -14 Million | - | -52.09 Million | -46.52 Million |
Effect of forex changes on cash | - | -1000.00 | 3000.00 | -904.00 | -1.00 | - |
Net cash flow / Change in cash | -8.43 Million | 6.81 Million | -5.3 Million | -108.11 Million | 100.58 Million | -29.3 Million |
Free Cash Flow | -72.63 Million | -65.5 Million | -1.1 Million | 135.19 Million | -11.12 Million | 78.97 Million |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 20.86 Million | 42.83 Million | -18.5 Million | -7.64 Million | 39.25 Million | 45.29 Million |
Depreciation & Amortization | - | 20.21 Million | - | 5.2 Million | 4.84 Million | 4.83 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -73.23 Million | - | - | - | - |
Other non-cash items | -20.86 Million | 69.69 Million | 18.5 Million | 7.64 Million | -39.25 Million | -45.29 Million |
Investing Cash Flow | - | 40.57 Million | - | - | - | - |
Investments in PPE | - | -3.36 Million | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | -5.56 Million | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | 49.5 Million | - | - | - | - |
Financing Cash Flow | - | 20.26 Million | - | - | - | - |
Debt repayment | - | -30.05 Million | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -9.79 Million | - | - | - | - |
Accounts receivables | - | -29.6 Million | - | - | - | - |
Accounts payables | - | -119.49 Million | - | - | - | - |
Inventory | - | 60.75 Million | - | - | - | - |
Other working capital | - | 15.11 Million | - | - | - | - |
Cash at beginning of period | - | 12.96 Million | - | 6.28 Million | -3.4 Million | 12.96 Million |
Cash at end of period | - | 4.52 Million | - | 16.7 Million | 6.28 Million | 22.62 Million |
Capital Expenditure | - | -3.36 Million | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | -8.43 Million | - | 10.41 Million | 9.69 Million | 9.66 Million |
Free Cash Flow | - | -72.63 Million | - | 10.41 Million | 9.69 Million | 9.66 Million |
UNITECH
NERV
GBIO
1522
REVB
KOCMT